From January 9, 2024 to March 31, 2024, the company has repurchased 2,946,800 shares, representing 1.9% for CNY 51.92 million. With this, the company has completed the repurchase of 2,946,800 shares, representing 1.9% for CNY 51.92 million under the buyback announced on January 9, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.39 CNY | -8.12% | +1.52% | -15.89% |
1st Jan change | Capi. | |
---|---|---|
-15.89% | 489M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 301201 Stock
- News ChengDa Pharmaceuticals Co., Ltd.
- Tranche Update on ChengDa Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on January 9, 2024.